WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that it is Chief Scientific Officer Dr. Kristi Snell presents at the International Symposium on Biopolymers (“ISBP”) 2022 Conference. The event will take place in Sion, Switzerland from September 12th to September 16th, 2022.

Dr. Snell will be speaking in a session entitled “Industrial Materials and Polymer Production,” scheduled for Friday, September 16, from 9:20-11:00 a.m. local time (3:20-5:00 a.m. ET). give a presentation. In her presentation, entitled “Breakthrough in Plant-Based Polyhydroxybutyrate (PHB) Production,” she described the successful engineering of her bacterial pathway to produce PHB in the cytosol of camelina seeds. increase.

Yield10 researchers are conducting a program aimed at producing sustainable, low-cost PHA bioplastic materials from the seeds of camelina plants. In a patent application filed in 2019, Yield10 described Camerina a new technological solution for deploying her PHB pathway. Using this approach, Yield10 obtained camelina plants that exhibited up to 10.2% PHB in their seeds with good germination and survival in the growth chamber. Subsequent field tests using lines containing the prototype Camelina PHB showed approximately 6% PHB in seeds for two consecutive years. In 2022, Yield10 planted his PHB-producing Camelina on an acre scale and harvested the plants for PHB extraction, product prototyping, sampling, and other business development activities. Development of elite PHA Camelina lines with yields in the 10-20% range and engineering of Camelina PHA copolymers is ongoing.

Dr. Kristi Snell, Chief Scientific Officer of Yield10 Bioscience, said: “This spring we have grown a prototype PHA Camelina at acre scale. We are now harvesting the crop and plan to extract the PHA from seeds for business development purposes. We have designed PHA production on a winter Camelina line that we plan to test for the first time in a field trial program in 2012. In moving forward with this program, we are committed to achieving PHA yields of 10-20% in Camelina seeds of field-grown plants. We are pursuing multiple strategies to reach our goals.”

For more information on ISBP 2022, please visit the conference website. A copy of Dr. Snell’s slide deck is available on the Yield10 Bioscience investor website.

PHA bioplastic background

Global plastic waste is estimated at 380 million tons per year. The largest market for plastics today is packaging materials, which account for nearly half of the plastic waste generated globally, most of which is neither recycled nor incinerated. In the future, at Camerina, he believes there is a great market opportunity to produce PHA biomaterials. PHA biomaterials (PHA) are natural microbial high molecular weight polymer storage polymers. These polymers are natural polyesters that can be recovered from the microorganisms that produce them and processed into a variety of product forms using standard plastic processing equipment. The production of PHA bioplastics in Camelina could represent a whole new market opportunity for farmers. This opportunity provides economic benefits to farmers, justifying the large-area adoption of camelina as a cover crop, and low-cost marketing of this product for new markets such as water treatment and sustainable biodegradable plastic replacement applications. There is a possibility that it will be possible to produce in

about camelina sativa

camelina sativaCommonly known as camelina or pseudoflax, it is an annual oilseed plant of the mustard family native to Europe. Camelina has the potential to replicate the development of modern canola from oilseed rape in an accelerated timeline based on modern technologies such as genomics and genome editing. In addition, Camelina grows on surrounding land, exhibits early maturity, is more drought and cold tolerant, and requires less input than other oilseed crops. With social conscience and sustainability in mind, Yield10 is leveraging his Camelina innovation to use it as a platform crop to produce low-carbon feedstocks for renewable fuels. omega-3 nutritional oils; high protein diets; PHA bioplastics.

about Yield10 Bioscience

Yield10 Bioscience, Inc. uses its differentiated trait gene discovery platform, “Trait Factory,” to develop improved Camelina varieties for the production of proprietary seed products, and to produce high-grade biomass for agriculture and agriculture. An agricultural bioscience company that discovers genetic traits of value. food industry. Our goal is to efficiently establish a high value seed products business based on the development of superior Camelina varieties that produce biofuel feedstock, PHA bioplastics and omega 3 (DHA+EPA) oil, Licensing and commercializing harvesting traits to major seed companies. Major row crops such as corn, soybeans, and canola. Yield10 is headquartered in Woburn, Massachusetts and has his Oilseeds Center of Excellence in Saskatoon, Canada.

For more information about the company, please visit www.yield10bio.com or follow the company on Twitter, Facebook and LinkedIn.

(YTEN-G)

safe harbor Foresight statement

This press release contains forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this release are not guarantees of future performance. Investors should be aware of the statements in this press release, which are not strictly historical, including but not limited to our plans for business development and field testing of Camerina. Company targets for his PHA yield of Camelina seeds. Our Belief on Market Opportunities for PHA Biomaterials and Bioplastics, It constitutes a forward-looking statement. Such forward-looking statements involve risks and uncertainties detailed in Yield10 Bioscience’s filings with the U.S. Securities and Exchange Commission, which could cause actual results to differ materially from expectations. subject to the risks and uncertainties of Yield10 does not undertake any obligation to update any forward-looking information with respect to any matter contained in or described in this press release.

contact address:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Brett Shapiro, (561) 479-8566, brets@coreir.com
Core IR Managing Director

Media inquiries:
Eric Fischgrand, eric@fischtankpr.com
fish tank PR